Emergency Department Clinicians' Needs for User-Centered Antibiotic Guideline: Insights from a Focus Group Interview
Abstract
BACKGROUND
Institution-specific antibiotic guidelines are core components of effective antibiotic stewardship programs; however, their practical use in emergency departments (EDs), where empirical antibiotic decisions are made under time pressure and diagnostic uncertainty, remains limited. This study explored ED clinicians' perspectives on antibiotic prescribing and identified key elements for developing ED-specific antibiotic guidelines.
MATERIALS AND METHODS
Focus group interviews were conducted between October 12 and October 26, 2022, at four tertiary hospitals in Korea. A total of 16 physicians participating directly in ED antibiotic prescribing were enrolled including Emergency medicine and internal medicine physicians. Interviews were recorded, transcribed and analyzed using thematic analysis by two infectious disease specialists.
RESULTS
Clinicians reported substantial challenges in prescribing empirical antibiotics, including diagnostic uncertainty, complex clinical scenarios, and practical prescribing issues such as dosing and administration details. Antibiotic decision-making was influenced by patient-related factors and institutional culture, including department-specific prescribing preferences. Existing antibiotic guidelines were infrequently used due to poor usability and limited applicability to real-world ED practice. Participants emphasized the need for concise, algorithm-based guidelines incorporating practical prescribing information and better…
Read the paper
Related studies
- The Matrisome: In Silico Definition and In Vivo Characterization by Proteomics of Normal and Tumor Extracellular Matrices
- The Escherichia coli MG1655 in silico metabolic genotype: Its definition, characteristics, and capabilities
- In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling
- In silico prediction of splice-altering single nucleotide variants in the human genome
- In silico clinical trials: how computer simulation will transform the biomedical industry
- In silico optimization of a guava antimicrobial peptide enables combinatorial exploration for peptide design
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.